Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
AuthorsHo, Kean F
Marchant, Thomas E
Moore, Christopher J
Webster, Gareth J
Rowbottom, Carl G
Lee, Lip W
Yap, Beng K
Sykes, Andrew J
Slevin, Nicholas J
AffiliationAcademic Radiation Oncology, The Christie NHS Foundation Trust, Manchester, UK. email@example.com
MetadataShow full item record
AbstractParotid-sparing head-and-neck intensity-modulated radiotherapy (IMRT) can reduce long-term xerostomia. However, patients frequently experience weight loss and tumor shrinkage during treatment. We evaluate the use of kilovoltage (kV) cone beam computed tomography (CBCT) for dose monitoring and examine if the dosimetric impact of such changes on the parotid and critical neural structures warrants replanning during treatment.
CitationMonitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. 2012, 82 (3):e375-82 Int J Radiat Oncol Biol Phys
JournalInternational Journal of Radiation Oncology, Biology, Physics